Welcome to
On Feet Nation
Cassie M. Stephens Online
goditac499 Online
Florence Online
AdisoniDiaz Online
William Online
Denise Online
Posted by Khalid Shaikh on August 4, 2024 at 7:15am 0 Comments 0 Likes
Posted by goditac499 on August 4, 2024 at 7:12am 0 Comments 0 Likes
The global Next-Generation Sequencing Services Market size is expected to reach USD 24.5 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 22.56% from 2023 to 2030. The development of next-generation sequencing (NGS) technologies has revolutionized gene sequencing in terms of reproducibility and cost savings. This has resulted in the introduction of several advancements in NGS technology to promote its usage in clinical labs and hospitals. Most current innovations in this field revolve around simplifying the usage of seq-technology and making it more sophisticated. These factors have driven the uptake of NGS services across various end-users.
Next-generation sequencing has progressed from research to clinical use in the last five years. Around 14 nations have launched large-scale genome sequencing programs, with nearly 60 million people expected to have their genome analyzed by 2025. Conventional disease testing service providers have broadened their portfolio with a rising trend of seq-based genetic tests. For instance, ARUP Laboratories announced the release of new coronavirus tests in March 2022, and IDbyDNA, Inc. partnered with another firm to introduce new coronavirus tests, an NGS test for respiratory illnesses, to aid physicians in evaluating patients with pneumonia and some other respiratory problems.
With the rising trend of high throughput sequencing within the pharma and biotech industry, there is a need for more developments to improve the speed and convenience of high throughput seq-platforms and simplify workflows. As a result, companies are focusing on the development of solutions to simplify the amplification and purification of samples and starting input. In March 2022, Illumina, Inc. announced the release of TruSigh Oncology (TSO) Comprehensive (EU), a comprehensive diagnostic that evaluates several tumor genes and indicators to identify a patient's cancer's individual molecular profile. The in vitro diagnostic (IVD) kit would assist in influencing genomic decisions for patients with cancer across Europe, with its global debut taking place first in Europe.
Related Press Release@ Next-Generation Sequencing Services Market Report
List of Key Players of Next-Generation Sequencing (NGS) Services Market
Next-generation Sequencing Services Market Report Highlights
Related Reports @
Targeted DNA/RNA Sequencing Market
Next Generation Sequencing Market
Next-generation Sequencing Services Market Segmentation
Grand View Research has segmented the global next-generation sequencing services market on the basis of service type, workflow, end-use, and region:
NGS Services Service Type Outlook (Revenue, USD Million, 2018 - 2030)
NGS Services Workflow Outlook (Revenue, USD Million, 2018 - 2030)
NGS Services End-use Outlook (Revenue, USD Million, 2018 - 2030)
NGS Services Regional Outlook (Revenue, USD Million, 2018 - 2030)
© 2024 Created by PH the vintage. Powered by
You need to be a member of On Feet Nation to add comments!
Join On Feet Nation